Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 8956 AL 8970

Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from computational approaches

Fatima G, Ashiquzzaman A, Kim SS, Kim YR, Kwon HS, Chung E.

Neurobiol Dis. 2025 May;208:106877. doi: 10.1016/j.nbd.2025.106877. Epub 2025 Mar 17.

Biomarkers of blood-brain barrier and neurovascular unit integrity in human cognitive impairment and dementia

French SR, Meyer BP, Arias JC, Levendovzsky SR, Weinkauf CC.

Alzheimers Dement. 2025 Mar;21(3):e70104. doi: 10.1002/alz.70104.

Scoping review exploring the impact of hip fracture in older adults with cognitive impairment or dementia

AbuAlrob H, Afeef VM, Shurman A, Shulkin A, Azizudin A, Hillier L, Ioannidis G, Thabane L, Griffith LE, Costa AP, Papaioannou A.

BMJ Open. 2025 Apr 27;15(4):e093893. doi: 10.1136/bmjopen-2024-093893.

Smartphone- and Tablet-Based Tools to Assess Cognition in Individuals With Preclinical Alzheimer Disease and Mild Cognitive Impairment: Scoping Review

van den Berg RL, van der Landen SM, Keijzer MJ, van Gils AM, van Dam M, Ziesemer KA, Jutten RJ, Harrison JE, de Boer C, van der Flier WM, Sikkes SA.

J Med Internet Res. 2025 May 27;27:e65297. doi: 10.2196/65297.

The Role of Periodontitis in Increasing Cognitive Decline in Alzheimer's Disease

Klonaris N, Murcia JDG, Patil S, Freitas CMT.

J Contemp Dent Pract. 2025 Mar 1;26(3):311-320. doi: 10.5005/jp-journals-10024-3847.

Therapeutic Targeting of the α7 Nicotinic Receptor: Challenges and Prospects for Cognitive Improvement in Alzheimer's and Schizophrenia

Magnussen JH.

Basic Clin Pharmacol Toxicol. 2025 Jul;137(1):e70061. doi: 10.1111/bcpt.70061.

Antiamyloid treatment for dementia: concerns outweigh hopes

Flicker L.

Curr Opin Psychiatry. 2025 Sep 1;38(5):355-360. doi: 10.1097/YCO.0000000000001021. Epub 2025 Jun 9.

[Cardiogenic dementia]

Esin RG, Gorobets EA, Mashtakova AI, Esin OR.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(8):43-49. doi: 10.17116/jnevro202512508143.

Brexpiprazole for the Treatment of Agitation in Older Adults with Alzheimer's Disease: A Systematic Review, Bayesian Meta-analysis, and Meta-regression

da Silva AMP, Falcão L, Ribeiro Gonçalves O, Virgilio Ribeiro F, Machado Magalhães PL, Lee Han M, Łajczak P, Letícia de Bastos Maximiano M, Cal H, de Souza Franco E, de Sousa Maia MB.

CNS Drugs. 2025 Nov;39(11):1071-1082. doi: 10.1007/s40263-025-01219-y. Epub 2025 Aug 31.

Epileptic variant in the spectrum of Alzheimer's disease - practical implications

Cretin B.

Seizure. 2025 May;128:133-139. doi: 10.1016/j.seizure.2024.09.015. Epub 2024 Sep 21.

Fast-spiking parvalbumin-positive interneurons: new perspectives of treatment and future challenges in dementia

Zhang X, Wu M, Cheng L, Cao W, Liu Z, Yang SB, Kim MS.

Mol Psychiatry. 2025 Feb;30(2):693-704. doi: 10.1038/s41380-024-02756-6. Epub 2024 Dec 18.

The impact of cognitive reserve relative to risk of Alzheimer's disease and rate of progression: an up-to-date review of the literature

Beveridge J, Sheth P, Thakkar S, Silverglate B, Grossberg G.

Expert Rev Neurother. 2025 Feb;25(2):175-187. doi: 10.1080/14737175.2024.2445015. Epub 2024 Dec 27.

The impact of sleep and exercise on brain atrophy in mild cognitive impairment

Mian M, Tahiri J, Habbal S, Aftan F, Reddy PH.

Mech Ageing Dev. 2025 Feb;223:112023. doi: 10.1016/j.mad.2024.112023. Epub 2024 Dec 26.

Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer's Disease

Ahlawat A, Walia V, Garg M.

Acta Neurol Belg. 2025 Aug;125(4):941-969. doi: 10.1007/s13760-024-02706-7. Epub 2025 Jan 7.

The role of lipid metabolism in cognitive impairment

Xu M, Wang L, Meng Y, Kang G, Jiang Q, Yan T, Che F.

Arq Neuropsiquiatr. 2025 Jan;83(1):1-13. doi: 10.1055/s-0044-1792097. Epub 2025 Jan 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias